HCA Healthcare (HCA) to Release Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA - Get Free Report) will be releasing its earnings data before the market opens on Friday, October 25th. Analysts expect HCA Healthcare to post earnings of $4.93 per share for the quarter. HCA Healthcare has set its FY 2024 guidance at 21.600-22.800 EPS.Persons that are interested in registering for the company's earnings conference call can do so using this link.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare's quarterly revenue was up 10.3% on a year-over-year basis. During the same period last year, the business posted $4.29 EPS. On average, analysts expect HCA Healthcare to post $23 EPS for the current fiscal year and $25 EPS for the next fiscal year.

HCA Healthcare Stock Up 2.3 %

HCA Healthcare stock traded up $9.19 during trading hours on Friday, reaching $415.67. The stock had a trading volume of 1,093,988 shares, compared to its average volume of 1,139,995. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a market cap of $108.87 billion, a price-to-earnings ratio of 20.72, a PEG ratio of 1.44 and a beta of 1.67. The business's 50 day moving average price is $392.18 and its 200-day moving average price is $350.18. HCA Healthcare has a 52 week low of $215.96 and a 52 week high of $417.14.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.64%. The ex-dividend date was Monday, September 16th. HCA Healthcare's payout ratio is 13.16%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on HCA. Oppenheimer boosted their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 24th. Wolfe Research raised HCA Healthcare to a "strong-buy" rating in a report on Thursday, August 29th. Barclays boosted their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 24th. Leerink Partners upped their price target on HCA Healthcare from $367.00 to $396.00 and gave the stock an "outperform" rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company boosted their target price on HCA Healthcare from $315.00 to $365.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 30th. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and an average target price of $365.65.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares of the company's stock, valued at approximately $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company's stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.